AstraZeneca and Trump Announce Drug Price Reduction Deal

AstraZeneca has reached a deal with President Trump to lower drug prices by providing discounts on certain medications for Medicaid. This agreement aims to make prescriptions more affordable for Americans and addresses tariff concerns. Trump's tariff threat was pivotal in securing this deal, reflecting ongoing efforts to negotiate better terms with pharmaceutical companies, which could significantly impact healthcare costs and consumer access to medications.